[ µÇ¼ | Êղر¾Õ¾ ]  
ÁªÏµµç»°£º15930175432  
×ÊÁÏÎÄÏ×£º
½ð˶Ê×Ò³ ¹ÇÁä,Ô¤²âÉí¸ß,Éú³¤Ñ§ÆÀ¼ÛÈí¼þ ¹ØÓÚÖлª05(¹ÇÁä±ê×¼-Öлª05½éÉÜ) ¹ÇÁä,Ô¤²âÉí¸ß,Éú³¤Ñ§ÆÀ¼ÛÈí¼þÉý¼¶ÓëÖ§³Ö ¹ÇÁä,Éú³¤Ñ§Ïà¹Ø×ÊÁÏÎÄÏ× ¹ÇÁä¼°Éú³¤Ñ§¿ÆÑ§Ñо¿³É¹û ¹ØÓÚ½ð˶ ÁªÏµÎÒÃÇ
¹ÇÁä,¹ÇÁäÆÀ¼Û,¹ÇÁä±ê×¼,Öлª05,Éí¸ßÔ¤²â,°«Éí¸ß×ÊÁÏ  ¹ØÓÚÖлª05

25.ΪʲôҪԤ²â°«Éí¸ß¶ùͯÖÎÁƹý³ÌÖеÄÉú³¤·´Ó¦

ÕªÒª

    ±¾ÎÄÊǽéÉÜйÇÁä±ê×¼-¡¶ÖйúÈËÊÖÍó¹Ç·¢Óý±ê×¼-Öлª05¡·ÏµÁÐÎÄÕµĵÚ25ƪ¡£²ûÊöÁËÔ¤²â°«Éí¸ß¶ùͯÖÎÁƹý³ÌÖÐÉú³¤·´Ó¦µÄ±ØÒªÐÔ¡£

¹Ø¼ü´Ê£º°«Éí¸ß,Éú³¤·´Ó¦

ÎÄÕÂ×÷Õߣº±¾Õ¾Ô­´´
×÷Õßµ¥Î»£º½ð˶Èí¼þ
¼ÈëÈÕÆÚ£º2010/3/3

    GHÖÎÁÆÌá¸ß°«Éí¸ß¶ùͯµÄÉú³¤ËٶȺÍ×îÖÕÉí¸ßÒѱ»Ëæ»ú»¯¡¢°²Î¿¼Á¶ÔÕÕÑо¿Ëù֤ʵ¡£Ò»°ãÒԹ̶¨¼ÁÁ¿µÄGHÖÎÁÆ3-7Ä꣬×îÖÕÉí¸ß±ÈÔ¤²âµÄ³ÉÄêÉí¸ßÔö¼Ó1SD¡£µ«×î½üWit et al.[1]Ñо¿ÁËÁ½ÖÖGH¼ÁÁ¿¶ÔÌØ·¢ÐÔ°«Éí¸ß¶ùͯ×îÖÕÉí¸ßºÍǰÁ½ÄêÉí¸ßËٶȵÄÓ°Ïì¡£²¡ÈË·ÖΪ0.24 mg/kg/ÖܼÁÁ¿×飻µÚÒ»Äê0.24 mg/kg/ÖÜ£¬È»ºóÒÔ0.37 mg/kg/ÖܼÁÁ¿×飻0.37 mg/kg/ÖܵļÁÁ¿×é¡£½á¹û£¬ÔÚ72Ãû½ÓÊÜ0.37 mg/kg/ÖܵIJ¡ÈËÉí¸ßËÙ¶ÈÏÔÖø¸ßÓÚ70Ãû½ÓÊܼÁÁ¿0.24 mg/kg/ÖܵIJ¡ÈË£¨ÖÎÁÆÐ§¹ûÏà²î= 0.8 cm/Äê; P = .003) £¬Ò²ÏÔÖø¸ßÓÚ67Ãû0.24-->0.37 mg/kg/ÖܼÁÁ¿×鲡ÈË (ÖÎÁÆÐ§¹ûÏà²î= 0.9 cm/Äê; P = .001) ¡£ÔÚ50Ãû²âÁ¿×îÖÕÉí¸ßµÄ²¡ÈËÖУ¬Èý×é¼ÁÁ¿×鯽¾ùÉí¸ß·Ö±ðÔö³¤1.55¡¢1.52ºÍ1.85 SDS£¬ÔÚ0.37 mg/kg/ÖܺÍ0.24 mg/kg/ÖܼÁÁ¿×éÖ®¼ä£¬ÖÎÁÆÐ§¹ûÏà²î0.57SD£¨3.6cm£¬P=.025£©£¬Æ½¾ù×ÜÉí¸ß¾»Ôö£¨×îÖÕÉí¸ß¼õÈ¥»ùÏßÔ¤²âÉí¸ß£©·Ö±ðΪ7.2cmºÍ5.4cm¡£Òò´Ë£¬ÔÚÌØ·¢ÐÔ°«Éí¸ß¶ùͯ£¬GHÖÎÁÆÔö¼ÓÉí¸ßËٶȺÍ×îÖÕÉí¸ß¾ßÓмÁÁ¿ÒÀÀµÐÔ¡£µ±1ÄêºóÔö¼ÓGH¼ÁÁ¿Ê±£¬Éí¸ßËÙ¶ÈÒ²Ôö¼Ó¡£

    ËäÈ»´æÔÚGH¼ÁÁ¿ÒÀÀµÐÔ£¬µ«ÊǽÓÊÜÏàͬ¼ÁÁ¿GHµÄ¶ùͯҲ¿É¼ûÉú³¤·´Ó¦µÄ¿í´ó±äÒì¡£Õý³£»òµÍÉú³¤ËٶȶùͯµÄGH·ÖÃÚÓëÉú³¤¹ØÏµµÄÑо¿ÏÔʾ£¬GH·ÖÃÚˮƽºÍÉí¸ßÖ®¼ä´æÔÚÕýÏà¹Ø¡£¾¡¹Ü´æÔÚÕâÖÖ¹ØÏµ£¬µ«ÈÔÔÚÉú³¤ËÙ¶ÈÀàËÆ¶ùͯ¹Û²ìµ½¿í´ó·¶Î§µÄѪÇåGHˮƽ£¬Ìáʾ¸öÌå¶ÔGHµÄ·´Ó¦´æÔÚ²îÒì¡£Òò´Ë£¬¶ÔÓÚ¶ùͯµÄÉú³¤À´Ëµ£¬GH·ÖÃÚºÍGH·´Ó¦¶¼ºÜÖØÒª¡£Ò»Ð©ÄÚÔ´ÐÔÒòËØ£¬ÀýÈç»ù±¾µÄÒÅ´«¶à̬ÐÔ¡¢ÒÅ´«Òì³£¡¢»ò³öÉúǰ/³öÉúºó³õÆÚµÄ´úл±ä»¯¿ÉÄÜÖÕÉúÓ°ÏìGH·ÖÃÚºÍÉú³¤·´Ó¦Ö®¼äµÄƽºâ¡£

    Òò´Ë£¬¹ú¼Ê¶ù¿ÆÄÚ·ÖÃÚѧ½çÌá³ö£¬ÒÀ¾Ý¶ÔGHÖÎÁƵÄÉú³¤·´Ó¦£¬Öƶ¨¸öÌ廯ÖÎÁÆ·½°¸µÄ½¨Ò飬²¢ÒÀ¾Ý´óÁ¿ÖÎÁÆÊý¾Ý½¨Á¢Á˲»Í¬²¡Òò°«Éí¸ß¶ùͯµÄÔ¤²âÉú³¤·´Ó¦Ä£ÐÍ¡£Í¨¹ýʹÓÃÕâЩԤ²âÄ£ÐÍ¿Éʹ¸öÌåGHÖÎÁƼÁÁ¿×î¼Ñ»¯[2]¡£Kristrom et al.[3]ÔÚ153ÃûÕï¶ÏΪÉú³¤¼¤ËØÈ±·¦£¨µ¥´¿GHD£©»òÌØ·¢ÐÔ°«Éí¸ß£¨ISS£©¶ùͯ£¬±È½ÏÁ˱ê×¼»¯¼ÁÁ¿ºÍÓÉÔ¤²âÄ£ÐͶøÈ·¶¨µÄ¸öÌ廯GH¼ÁÁ¿µÄÉú³¤·´Ó¦£¬ÒÔ²âÁ¿Éí¸ßSDSÓë¸öÌ常ĸÉí¸ßÖÐÖµSDS£¨MPH SDS£©Ö®²î £¨diffMPHSDS£©Îª½á¹ûÖ¸±ê¡£Ñо¿½á¹û±íÃ÷£¬¸öÌ廯¼ÁÁ¿×éµÄdiffMPHSDS·¶Î§±È±ê×¼¼ÁÁ¿×é¼õСÁË32%£¨P < 0.003£©£¬¶øÆ½¾ùdiffMPHSDSÏàËÆ£º·Ö±ðΪ£­0.42¡À0.46 ºÍ £­0.48¡À0.67¡£GHȱ·¦ºÍISS×é¶ùͯGHÖÎÁÆ0-2ÄêµÄÉí¸ßSDSÔö³¤Ò²ÏàËÆ£¬·Ö±ðΪ1.31¡À0.47 ºÍ 1.36¡À0.47¡£Òò´Ë£¬µÃ³öÔÚ¿ªÊ¼GH ÖÎÁƺóµÄ¸ÏÉÏÉú³¤ÆÚ¼ä£¬¸öÌ廯GH¼ÁÁ¿ÏÔÖø¼õСÁË´ïµ½¸öÌåÔ¤ÆÚÉú³¤Ä¿±êºÃ»ò»µµÄ¶ùͯµÄ±ÈÀý£¬¼õСÁËÉú³¤·´Ó¦µÄ¿É±äÐÔ¡£

    ËùÒÔ£¬ÒÀ¾Ý»ùÏßÉú³¤Ñ§ÒòËØ£¬Ô¤²â¸öÌå°«Éí¸ß¶ùͯÖÎÁƹý³ÌÖеÄÉú³¤·´Ó¦£¬¿ÉÈ·¶¨¸öÌåÉí¸ßÔö³¤´ïµ½Ô¤ÆÚÄ¿µÄ¶øÓ¦²ÉÓõÄ×î¼ÑGHÖÎÁƼÁÁ¿£¬²¢¿ÉÔÚÖÎÁƹý³ÌÖиù¾ÝÉú³¤·´Ó¦Ô¤²âµ÷ÕûÖÎÁÆ·½°¸¡£

²Î¿¼ÎÄÏ×

[1] Wit JM, Rekers-Mombarg LT, Cutler GB, et al. Growth hormone (GH) treatment to final height in children with
    idiopathic short stature: evidence for a dose effect. J Pediatr, 2005, 146(1):45-53.

[2] Keni J and Cohen P. Optimizing Growth Hormone Dosing in Children with Idiopathic Short Stature. Horm Res
     2009;71(suppl 1):70¨C74

[3] Kristrom B, Aronson AS, Dahlgren J, et al. Growth Hormone (GH) Dosing during Catch-Up Growth Guided by
     Individual Responsiveness Decreases Growth Response Variability in Prepubertal Children with GH
     Deficiency or Idiopathic Short Stature. J Clin Endocrinol Metab, 2009, 94:483¨C490.

Ïà¹ØÎÄÕÂ
    Ïà¹Ø¹«¸æºÍÐÂÎÅ

      ·µ»ØÉÏÒ»Ò³ 
        Óû§µÇ¼
      ÕË ºÅ£º
      ÃÜ Â룺
        
        ¹ØÓÚÖлª05
        ×ÊÁÏÎÄÏ× ¸ü¶à>>  
      »Øµ½¶¥¶Ë 
      ·µ»ØÊ×Ò³ | ÉèΪÊ×Ò³ | ¼ÓÈëÊÕ²Ø
      ½ð˶Èí¼þ@°æÈ¨ËùÓÐ ¼½ICP±¸10004166ºÅ Email£º28655941@qq.com µç»°£º15930175432